The GOP senator and former physician expressed misgivings about whether Trump’s controversial HHS pick could be trusted with ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services (HHS) secretary, sat through his second Senate ...

Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as ...

Should Kennedy gain confirmation, he would oversee HHS’s $1.7 trillion budget and hold influence over the foods and drugs that affect the daily lives of Americans.

A show trial is an official proceeding that is conducted primarily for propaganda purposes rather than a tribunal seeking ...

Staff turnover in Iowa nursing home continues to climb 15 years after legislators approved, but didn't fund, an effort to address the issue.

A new study finds differences in spending on long-term services and supports (LTSS) between people with dual eligibility for ...

Trump’s nominee for Health and Human Services secretary said that NIH, FDA and CDC would be integral in his objective to prevent chronic disease.

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact ...

How Yale New Haven Health navigates Medicare Advantage complexities, strengthens provider partnerships, and fosters leadership within the system.